L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis

Summary

A major challenge of peritoneal dialysis (PD) therapy is the development of glucose-sparing strategies able to provide an efficacious ultrafiltration (UF) profile. Study hypothesis is to evaluate the possibility to formulate PD solutions containing L-carnitine as an osmotic agent to partially replace glucose.

Timeline

Start

2009-06

Primary completion

2012-10

Completion

2012-12

Drugs

Indications